Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected] Learn more

pHAGE EF1α dCas9-NED
(Plasmid #109369)

Ordering

Item Catalog # Description Quantity Price (USD)
Plasmid 109369 Standard format: Plasmid sent in bacteria as agar stab 1 $75

This material is available to academics and nonprofits only.

Backbone

  • Vector backbone
    pHAGE EF1α dCas9-VP64 (Addgene plasmid #50918)
  • Backbone manufacturer
    Rene Maehr, Scot Wolfe
  • Backbone size (bp) 12547
  • Modifications to backbone
    The ORF encoding VP64 was excised from pHAGE EF1α dCas9-VP64 by BamHI-NotI double digestion and replaced with an oligonucleotide containing MluI and AsiSI restriction sites.
  • Vector type
    Mammalian Expression, Lentiviral, CRISPR
  • Promoter EF-1α
  • Selectable markers
    Puromycin
  • Tag / Fusion Protein
    • 3xHA (N terminal on backbone)

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin
  • Growth Temperature
    37°C
  • Growth Strain(s)
    NEB Stable
  • Copy number
    High Copy

Cloning Information

Resource Information

  • A portion of this plasmid was derived from a plasmid made by
    Rene Maehr and Scot Wolfe, pHAGE EF1α dCas9-VP64 (Addgene plasmid #50918).
  • Terms and Licenses
  • Industry Terms
    • Not Available to Industry
  • Article Citing this Plasmid

Depositor Comments

The DNA fragment encoding the effector domain is synthesized by PCR and cloned between the MluI and AsiSI sites of pHAGE EF1α dCas9-NED to create in-frame fusion between dCas9 (D10A, H840A) and the effector domain. If the experimental strategy requires testing the effector domain in a transient transfection system before establishing stably expressing cell lines, it is recommended to construct the dCas9-effector domain fusion first in pdCas9-NED (Addgene plasmid #109358), then excise the coding sequence of the effector domain by AscI-PacI double digestion, and clone the fragment between the MluI and AsiSI sites of pHAGE EF1α dCas9-NED. Ligation of the MluI end to the compatible AscI end preserves the reading frame (Goubert et al. 2018).

How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pHAGE EF1α dCas9-NED was a gift from Antal Kiss (Addgene plasmid # 109369 ; http://n2t.net/addgene:109369 ; RRID:Addgene_109369)
  • For your References section:

    Establishment of Cell Lines Stably Expressing dCas9-Fusions to Address Kinetics of Epigenetic Editing. Goubert D, Koncz M, Kiss A, Rots MG. Methods Mol Biol. 2018;1767:395-415. doi: 10.1007/978-1-4939-7774-1_22. 10.1007/978-1-4939-7774-1_22 PubMed 29524148